Supplementary Table 1 for Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration’s September 1,2021, data safety communication
收藏Mendeley Data2026-04-18 收录
下载链接：
https://data.mendeley.com/datasets/m23y6ryhv7
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Table 1 for Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration’s September 1,2021, data safety communication.
创建时间：
2022-04-27
